PHARMACIE AKKARI JAMME : revenue, balance sheet and financial ratios

PHARMACIE AKKARI JAMME is a French company founded 11 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in SALSES-LE-CHATEAU (66600), this company of category PME shows in 2022 a revenue of 3.1 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE AKKARI JAMME (SIREN 805301074)
Indicator 2024 2023 2022 2021 2020 2019 2018 2017 2016
Revenue N/C N/C 3 069 821 € 3 371 671 € 2 793 894 € 2 573 465 € 2 405 222 € 2 412 013 € 2 411 443 €
Net income -53 884 € 0 € 206 389 € 472 555 € 189 481 € 160 141 € 189 814 € 183 275 € 194 572 €
EBITDA N/C N/C 205 255 € 579 458 € 237 595 € 162 185 € 200 583 € 204 465 € 299 017 €
Net margin N/C N/C 6.7% 14.0% 6.8% 6.2% 7.9% 7.6% 8.1%

Revenue and income statement

In 2024, PHARMACIE AKKARI JAMME records a net loss of 54 k€. This deficit will reduce equity on the balance sheet.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-53 884 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 71%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 50%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

71.09%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

49.792%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

77.9%

Solvency indicators evolution
PHARMACIE AKKARI JAMME

Sector positioning

Debt ratio
71.09 2024
2022
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Average +19 pts over 3 years

In 2024, the debt ratio of PHARMACIE AKKARI JAMME (71.09) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
49.79% 2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average -21 pts over 3 years

In 2024, the financial autonomy of PHARMACIE AKKARI JAMME (49.8%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
3.47 years 2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Good

In 2022, the repayment capacity of PHARMACIE AKKARI JAMME (3.47) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 257.24. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

257.239

Liquidity indicators evolution
PHARMACIE AKKARI JAMME

Sector positioning

Liquidity ratio
257.24 2024
2022
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Good

In 2024, the liquidity ratio of PHARMACIE AKKARI JAMME (257.24) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Interest coverage
5.3x 2022
2022
Q1: 0.75x
Med: 2.51x
Q3: 5.16x
Excellent

In 2022, the interest coverage of PHARMACIE AKKARI JAMME (5.3x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
PHARMACIE AKKARI JAMME

Positioning of PHARMACIE AKKARI JAMME in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE AKKARI JAMME with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE AKKARI JAMME

What is the revenue of PHARMACIE AKKARI JAMME ?

The revenue of PHARMACIE AKKARI JAMME in 2022 is 3.1 M€.

Is PHARMACIE AKKARI JAMME profitable?

PHARMACIE AKKARI JAMME recorded a net loss in 2024.

Where is the headquarters of PHARMACIE AKKARI JAMME ?

The headquarters of PHARMACIE AKKARI JAMME is located in SALSES-LE-CHATEAU (66600), in the department Pyrenees-Orientales.

Where to find the tax return of PHARMACIE AKKARI JAMME ?

The tax return of PHARMACIE AKKARI JAMME is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE AKKARI JAMME operate?

PHARMACIE AKKARI JAMME operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.